Propel Bio Management, LLC / AQST
Propel Bio Management, LLC’s Aquestive Therapeutics Inc Position
Does Propel Bio Management, LLC own Aquestive Therapeutics Inc (AQST)? Yes — 711.0K shares worth $3M (+1.86% of its 13F portfolio) as of Q1 2026.
Position Value
$3M
Q1 2026
Shares
711.0K
% of Portfolio
+1.86%
Quarters Held
1
currently held
Position History AQST
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 711.0K | $3M | +1.86% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of AQST.